JD, PhD, is an assistant professor at the University of California, Berkeley’s School of Public Health in the Department of Community Health Sciences. His research has been funded by the National ...

This article discusses litigation over the new rule as well as the rule’s changes to prohibit the coverage of treatment for ...

Recently, the Second Circuit, Sixth Circuit, and a Texas district again rejected the pharmaceutical industry’s challenges to ...

By focusing on three priorities—one corresponding to each goal—the Center for Medicare and Medicaid Innovation’s leaders can ...

Additional deregulatory action is assured across a wide range of agencies, especially as the administration is reportedly ...

One way to save Medicaid money while ensuring that funds are spent to improve staffing and services is to substantially ...

As transformative as they may be for patients, cell and gene therapies are creating new kinds of uncertainty and challenges ...

By combining the ETHIC bill and a legislative formulation of a withdrawn USPTO rule, Congress has an opportunity to enact ...

Health Affairs' Rob Lott interviews Steven M. Lieberman of the University of Southern California, Los Angeles on his recent ...

Health Affairs' Jeff Byers welcomes Senior Editor Kathleen Haddad back to the pod to take a look at recent news that HHS ...

This particular case concerns access to COVID vaccinations for two vulnerable groups, pregnant women and children, but more ...

Reducing the rates at which mothers and infants die and eliminating inequities in survival are possible only when a strategic ...